The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Open accessAbstract
SUMMARY When type III interferon (IFN-λ; also known as interleukin-28 (IL-28) and IL-29) was discovered in 2003, its antiviral function was expected to be analogous to the type I IFNs (IFN-α and IFN-β), via the induction of IFN-stimulated genes (ISGs). While IFN-λ stimulates expression of antiviral ISGs preferentially in cells of epithelial origin, recent studies have defined additional antiviral mechanisms in other cell types and tissues. Models of viral infection using mice lacking IFN-λ signaling and single nucleotide polymorphism (SNP) associations with human disease have expanded our understanding of the contribution of IFN-λ to the antiviral response at anatomic barriers and the immune response beyond these barriers. In this review, we highlight recent insights into the functions of IFN-λ, including its ability to restrict virus spread into the brain and to clear chronic viral infections in the gastrointestinal tract. We also discuss how IFN-λ modulates innate and adaptive immunity, autoimmunity, and tumor progression and its possible therapeutic applications in human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,826
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2 (2010) · Nature Genetics · doi:10.1038/ng.694 · Cited by 1,047
Role of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 928
Replication of Norovirus in Cell Culture Reveals a Tropism for Dendritic Cells and Macrophages
Wobus, C. E., Karst, S. M., Thackray, L. B., Chang, K.-O., Sosnovtsev, S. V., Belliot, G., Krug, A., Mackenzie, J. M., Green, K. Y., & Virgin, H. W. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020432 · Cited by 833
Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000017 · Cited by 772
Enteric bacteria promote human and mouse norovirus infection of B cells
Jones, M. K., Watanabe, M., Zhu, S., Graves, C. L., Keyes, L. R., Grau, K. R., Gonzalez-Hernandez, M. B., Iovine, N. M., Wobus, C. E., Vinjé, J., et al. (2014) · Science · doi:10.1126/science.1257147 · Cited by 769
Intestinal Microbiota Promote Enteric Virus Replication and Systemic Pathogenesis
Kuss, S. K., Best, G. T., Etheredge, C. A., Pruijssers, A. J., Frierson, J. M., Hooper, L. V., Dermody, T. S., & Pfeiffer, J. K. (2011) · Science · doi:10.1126/science.1211057 · Cited by 629
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4501-4509.2006 · Cited by 596
Virus Infections in the Nervous System
Koyuncu, O. O., Hogue, I. B., & Enquist, L. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.010 · Cited by 594
Marcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., & Uzé, G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324610 · Cited by 490
Zhou, Z., Hamming, O. J., Ank, N., Paludan, S. R., Nielsen, A. L., & Hartmann, R. (2007) · Journal of Virology · doi:10.1128/jvi.02438-06 · Cited by 479
Perera, G. K., Di Meglio, P., & Nestle, F. O. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132448 · Cited by 462
Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00272-10 · Cited by 443
Interferon-Lambda: A New Addition to an Old Family
Donnelly, R. P., & Kotenko, S. V. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0078 · Cited by 420
An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity
Ank, N., Iversen, M. B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U. B., Dagnaes-Hansen, F., Thomsen, A. R., Chen, Z., Haugen, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2474 · Cited by 419
IFN-λ determines the intestinal epithelial antiviral host defense
Pott, J., Mahlakõiv, T., Mordstein, M., Duerr, C. U., Michiels, T., Stockinger, S., Staeheli, P., & Hornef, M. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100552108 · Cited by 416
Sato, S., Li, K., Kameyama, T., Hayashi, T., Ishida, Y., Murakami, S., Watanabe, T., Iijima, S., Sakurai, Y., Watashi, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.016 · Cited by 413
Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection
Baldridge, M. T., Nice, T. J., McCune, B. T., Yokoyama, C. C., Kambal, A., Wheadon, M., Diamond, M. S., Ivanova, Y., Artyomov, M., & Virgin, H. W. (2015) · Science · doi:10.1126/science.1258025 · Cited by 412
Self-citationInterferons and viruses: an evolutionary arms race of molecular interactions
Hoffmann, H.-H., Schneider, W. M., & Rice, C. M. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.004 · Cited by 410
The Interferons: 50 Years after Their Discovery, There Is Much More to Learn
Pestka, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700004200 · Cited by 392
Diverse intracellular pathogens activate type III interferon expression from peroxisomes
Odendall, C., Dixit, E., Stavru, F., Bierne, H., Franz, K. M., Durbin, A. F., Boulant, S., Gehrke, L., Cossart, P., & Kagan, J. C. (2014) · Nature Immunology · doi:10.1038/ni.2915 · Cited by 374
Successful Transmission of a Retrovirus Depends on the Commensal Microbiota
Kane, M., Case, L. K., Kopaskie, K., Kozlova, A., MacDearmid, C., Chervonsky, A. V., & Golovkina, T. V. (2011) · Science · doi:10.1126/science.1210718 · Cited by 367
Urban, T. J., Thompson, A. J., Bradrick, S. S., Fellay, J., Schuppan, D., Cronin, K. D., Hong, L., McKenzie, A., Patel, K., Shianna, K. V., et al. (2010) · Hepatology · doi:10.1002/hep.23912 · Cited by 361
Norovirus Gastroenteritis in Immunocompromised Patients
Bok, K., & Green, K. Y. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1207742 · Cited by 358
Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism
Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H., & Fujita, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608618200 · Cited by 355
Doyle, S. E., Schreckhise, H., Khuu‐Duong, K., Henderson, K., Rosler, R., Storey, H., Yao, L., Liu, H., Barahmand‐pour, F., Sivakumar, P., et al. (2006) · Hepatology · doi:10.1002/hep.21312 · Cited by 348
Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity
Nice, T. J., Baldridge, M. T., McCune, B. T., Norman, J. M., Lazear, H. M., Artyomov, M., Diamond, M. S., & Virgin, H. W. (2015) · Science · doi:10.1126/science.1258100 · Cited by 345
Self-citationNew Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation
Leung, D. Y. M. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0564 · Cited by 331
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.-C., Paludan, S. R., Klucher, K., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 325
Österlund, P. I., Pietilä, T. E., Veckman, V., Kotenko, S. V., & Julkunen, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3434 · Cited by 301
Viral infections in atopic dermatitis
Wollenberg, A., Wetzel, S., Burgdorf, W. H. C., & Haas, J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.07.001 · Cited by 300
Sabat, R. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.11.001 · Cited by 298
Dumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., & Renauld, J.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404789200 · Cited by 291
Hernández, P. P., Mahlakõiv, T., Yang, I., Schwierzeck, V., Nguyen, N., Guendel, F., Gronke, K., Ryffel, B., Hölscher, C., Dumoutier, L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3180 · Cited by 287
Mouse CD8α+ DCs and human BDCA3+ DCs are major producers of IFN-λ in response to poly IC
Lauterbach, H., Bathke, B., Gilles, S., Traidl-Hoffmann, C., Luber, C. A., Fejer, G., Freudenberg, M. A., Davey, G. M., Vremec, D., Kallies, A., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092720 · Cited by 278
François-Newton, V., Magno de Freitas Almeida, G., Payelle-Brogard, B., Monneron, D., Pichard-Garcia, L., Piehler, J., Pellegrini, S., & Uzé, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022200 · Cited by 269
Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., & Wack, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003773 · Cited by 269
Thomas, E., Gonzalez, V. D., Li, Q., Modi, A. A., Chen, W., Noureddin, M., Rotman, Y., & Liang, T. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.055 · Cited by 266
Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo
Jewell, N. A., Cline, T., Mertz, S. E., Smirnov, S. V., Flaño, E., Schindler, C., Grieves, J. L., Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.01703-09 · Cited by 263
Lasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3653 · Cited by 254
Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN
Zhang, X., Brann, T. W., Zhou, M., Yang, J., Oguariri, R. M., Lidie, K. B., Imamichi, H., Huang, D.-W., Lempicki, R. A., Baseler, M. W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003389 · Cited by 249
Daniels, B. P., Holman, D. W., Cruz-Orengo, L., Jujjavarapu, H., Durrant, D. M., & Klein, R. S. (2014) · mBio · doi:10.1128/mbio.01476-14 · Cited by 235
Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier
Lazear, H. M., Daniels, B. P., Pinto, A. K., Huang, A. C., Vick, S. C., Doyle, S. E., Gale, M., Klein, R. S., & Diamond, M. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4304 · Cited by 234
Self-citationAntiviral Immune Responses of Bats: A Review
Baker, M. L., Schountz, T., & Wang, L. ‐. (2013) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2012.01528.x · Cited by 232
Interferon induction and function at the mucosal surface
Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2013) · Immunological Reviews · doi:10.1111/imr.12101 · Cited by 220
Mahlakõiv, T., Hernandez, P., Gronke, K., Diefenbach, A., & Staeheli, P. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004782 · Cited by 216
IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production
Blazek, K., Eames, H. L., Weiss, M., Byrne, A. J., Perocheau, D., Pease, J. E., Doyle, S., McCann, F., Williams, R. O., & Udalova, I. A. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140995 · Cited by 216
Karst, S. M., Wobus, C. E., Goodfellow, I. G., Green, K. Y., & Virgin, H. W. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.05.015 · Cited by 209
Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Übel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100142 · Cited by 207
Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response
Jordan, W. J., Eskdale, J., Srinivas, S., Pekarek, V, Kelner, D., Rodia, M., & Gallagher, G. (2007) · Genes & Immunity · doi:10.1038/sj.gene.6364382 · Cited by 206
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction
Bibert, S., Roger, T., Calandra, T., Bochud, M., Cerny, A., Semmo, N., Duong, F. H. T., Gerlach, T., Malinverni, R., Moradpour, D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130012 · Cited by 201
Witte, K., Gruetz, G., Volk, H.-D., Looman, A. C., Asadullah, K., Sterry, W., Sabat, R., & Wolk, K. (2009) · Genes & Immunity · doi:10.1038/gene.2009.72 · Cited by 198
Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family
Gad, H. H., Dellgren, C., Hamming, O. J., Vends, S., Paludan, S. R., & Hartmann, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002923 · Cited by 196
Antitumor Activity of IFN-λ in Murine Tumor Models
Sato, A., Ohtsuki, M., Hata, M., Kobayashi, E., & Murakami, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7686 · Cited by 195
Hamming, O. J., Terczyńska‐Dyla, E., Vieyres, G., Dijkman, R., Jørgensen, S. E., Akhtar, H., Siupka, P., Pietschmann, T., Thiel, V., & Hartmann, R. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.232 · Cited by 194
A Bacterial Protein Targets the BAHD1 Chromatin Complex to Stimulate Type III Interferon Response
Lebreton, A., Lakisic, G., Job, V., Fritsch, L., Tham, T. N., Camejo, A., Matteï, P.-J., Regnault, B., Nahori, M.-A., Cabanes, D., et al. (2011) · Science · doi:10.1126/science.1200120 · Cited by 193
Bolen, C. R., Ding, S., Robek, M. D., & Kleinstein, S. H. (2014) · Hepatology · doi:10.1002/hep.26657 · Cited by 193
Kotenko, S. V. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.007 · Cited by 193
Type I interferonopathies: Mendelian type I interferon up-regulation
Crow, Y. J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.005 · Cited by 190
Type I interferons: diversity of sources, production pathways and effects on immune responses
Swiecki, M. K., & Colonna, M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.026 · Cited by 183
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
OʼBrien, T. R., Prokunina‐Olsson, L., & Donnelly, R. P. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0136 · Cited by 176
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
Eslam, M., Hashem, A. M., Leung, R., Romero-Gomez, M., Berg, T., Dore, G. J., Chan, H. L. K., Irving, W. L., Sheridan, D., Abate, M. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7422 · Cited by 176
Human interferon-λ3 is a potent member of the type III interferon family
Dellgren, C., Gad, H. H., Hamming, O. J., Melchjorsen, J., & Hartmann, R. (2009) · Genes & Immunity · doi:10.1038/gene.2008.87 · Cited by 170
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
Marukian, S., Andrus, L., Sheahan, T. P., Jones, C. T., Charles, E. D., Ploss, A., Rice, C. M., & Dustin, L. B. (2010) · Hepatology · doi:10.1002/hep.24580 · Cited by 167
Okabayashi, T., Kojima, T., Masaki, T., Yokota, S.-I., Imaizumi, T., Tsutsumi, H., Himi, T., Fujii, N., & Sawada, N. (2011) · Virus Research · doi:10.1016/j.virusres.2011.07.011 · Cited by 165
Interferon-beta: Mechanism of action and dosing issues
Markowitz, C. E. (2007) · Neurology · doi:10.1212/01.wnl.0000277703.74115.d2 · Cited by 163
Egli, A., Santer, D. M., O’Shea, D., Tyrrell, D. L., & Houghton, M. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.51 · Cited by 160
Lampertico, P., Viganò, M., Cheroni, C., Facchetti, F., Invernizzi, F., Valveri, V., Soffredini, R., Abrignani, S., De Francesco, R., & Colombo, M. (2013) · Hepatology · doi:10.1002/hep.25749 · Cited by 159
Morrow, M. P., Pankhong, P., Laddy, D. J., Schoenly, K. A., Yan, J., Cisper, N. J., & Weiner, D. B. (2009) · Blood · doi:10.1182/blood-2008-11-190520 · Cited by 152
McFarland, A. P., Horner, S. M., Jarret, A. P., Joslyn, R. C., Bindewald, E., Shapiro, B. A., Delker, D. A., Hagedorn, C. H., Carrington, M. N., Gale, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2758 · Cited by 147
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Muir, A. J., Arora, S., Everson, G. T., Flisiak, R., George, J., Ghalib, R. H., Gordon, S. C., Gray, T. E., Greenbloom, S., Hassanein, T., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.022 · Cited by 145
Park, H., Serti, E., Eke, O. F., Muchmore, B., Prokunina‐Olsson, L., Capone, S., Folgori, A., & Rehermann, B. (2012) · Hepatology · doi:10.1002/hep.25897 · Cited by 143
IL-29 Is Produced by T H 17 Cells and Mediates the Cutaneous Antiviral Competence in Psoriasis
Wolk, K., Witte, K., Witte, E., Raftery, M., Kokolakis, G., Philipp, S., Schönrich, G., Warszawska, K., Kirsch, S., Prösch, S., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006245 · Cited by 136
Interferon-λ in the Context of Viral Infections: Production, Response and Therapeutic Implications
Hermant, P., & Michiels, T. (2014) · Journal of Innate Immunity · doi:10.1159/000360084 · Cited by 134
IL-28 Elicits Antitumor Responses against Murine Fibrosarcoma
Numasaki, M., Tagawa, M., Iwata, F., Suzuki, T., Nakamura, A., Okada, M., Iwakura, Y., Aiba, S., & Yamaya, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5086 · Cited by 133
Contrasting disease patterns in psoriasis and atopic dermatitis
Christophers, E., & Henseler, T. (1987) · Archives of Dermatological Research · doi:10.1007/bf00585919 · Cited by 132
Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29)
Jordan, W. J., Eskdale, J., Boniotto, M., Rodia, M. T., Kellner, D. B., & Gallagher, G. E. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364348 · Cited by 128
The role of transposable elements in the regulation of IFN-λ1 gene expression
Thomson, S. J. P., Goh, F. G., Banks, H., Krausgruber, T., Kotenko, S. V., Foxwell, B. M. J., & Udalova, I. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904477106 · Cited by 127
Dai, J., Megjugorac, N. J., Gallagher, G. E., Yu, R. Y.-L., & Gallagher, G. E. (2009) · Blood · doi:10.1182/blood-2008-09-179507 · Cited by 126
Nice, T. J., Strong, D. W., McCune, B. T., Pohl, C. S., & Virgin, H. W. (2012) · Journal of Virology · doi:10.1128/jvi.01864-12 · Cited by 124
Self-citationKim, H. J., Kim, C., Ryu, J.-H., Kim, M., Park, C. Y., Lee, J. M., Holtzman, M. J., & Yoon, J. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0003oc · Cited by 121
Early Steps in Rotavirus Cell Entry
López, S., & Arias, C. F. (2006) · Springer eBooks · doi:10.1007/3-540-30773-7_2 · Cited by 118
Dickensheets, H. L., Sheikh, F. G., Park, O., Gao, B., & Donnelly, R. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812395 · Cited by 112
Mechanisms of Type III Interferon Expression
Iversen, M. B., & Paludan, S. R. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0063 · Cited by 112
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
Egli, A., Santer, D. M., O’Shea, D., Barakat, K., Syedbasha, M., Vollmer, M., Baluch, A., Bhat, R. K., Groenendyk, J., Joyce, M., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004556 · Cited by 110
Hillyer, P., Mane, V. P., Schramm, L. M., Puig, M., Verthelyi, D. I., Chen, A., Zhao, Z., Navarro, M. B., Kirschman, K. D., Bykadi, S., et al. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2011.109 · Cited by 110
Zhou, P., Cowled, C. J., Todd, S., Crameri, G. S., Virtue, E. R., Marsh, G. A., Klein, R., Shi, Z., Wang, L., & Baker, M. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003115 · Cited by 107
Genetics of IL28B and HCV—response to infection and treatment
Hayes, C. N., Imamura, M., Aikata, H., & Chayama, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.101 · Cited by 106
Regulation of apoptosis by type III interferons
Li, W., Lewis-Antes, A., Huang, J., Balan, M., & Kotenko, S. V. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00558.x · Cited by 106
Srinivas, S., Dai, J., Eskdale, J., Gallagher, G. E., Megjugorac, N. J., & Gallagher, G. E. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02862.x · Cited by 105
Burkart, C., Arimoto, K., Tang, T., Cong, X., Xiao, N., Liu, Y., Kotenko, S. V., Ellies, L. G., & Zhang, D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201864 · Cited by 105
The unique regulation and functions of type III interferons in antiviral immunity
Odendall, C., & Kagan, J. C. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.02.003 · Cited by 103
Bierne, H., Travier, L., Mahlakõiv, T., Tailleux, L., Subtil, A., Lebreton, A., Anupam, P., Gicquel, B., Staeheli, P., Lecuit, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039080 · Cited by 103
NK cells require IL-28R for optimal in vivo activity
Souza-Fonseca-Guimarães, F., Young, A., Mittal, D., Martinet, L., Bruedigam, C., Takeda, K., Andoniou, C. E., Degli‐Esposti, M. A., Hill, G. R., & Smyth, M. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424241112 · Cited by 101
Iversen, M. B., Ank, N., Melchjorsen, J., & Paludan, S. R. (2010) · Journal of Virology · doi:10.1128/jvi.02591-09 · Cited by 99
Wongthida, P., Díaz, R. M., Galivo, F., Kottke, T. J., Thompson, J., Pulido, J. S., Pavelko, K. D., Pease, L. R., Melcher, A. A., & Vile, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4658 · Cited by 99
Sheahan, T. P., Imanaka, N., Marukian, S., Dorner, M., Liu, P., Ploß, A., & Rice, C. M. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.01.007 · Cited by 98
Key, F. M., Lewis, B. P., Dennis, M. Y., Huerta‐Sánchez, E., Tang, W., Prokunina‐Olsson, L., Nielsen, R., & Andrés, A. M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004681 · Cited by 96
Griffiths, S. J., Koegl, M., Boutell, C., Zenner, H. L., Crump, C. M., Pica, F., Gonzalez, O., Friedel, C. C., Barry, G., Martin, K., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003514 · Cited by 93
Bacterial Pathogens Activate a Common Inflammatory Pathway through IFNλ Regulation of PDCD4
Cohen, T. S., & Prince, A. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003682 · Cited by 91
Génin, P., Lin, R., Hiscott, J. B., & Civas, A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01805-08 · Cited by 90
Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1
Miknis, Z. J., Magracheva, E., Li, W., Zdanov, A. S., Kotenko, S. V., & Wlodawer, A. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.09.068 · Cited by 85
RNA degradation in antiviral immunity and autoimmunity
Rigby, R. E., & Rehwinkel, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.001 · Cited by 84
Interfering with immunity: detrimental role of type I IFNs during infection
Stifter, S. A., & Feng, C. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402794 · Cited by 78
Fox, J. M., Crabtree, J. M., Sage, L. K., Tompkins, S. M., & Tripp, R. A. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0052 · Cited by 77
The use of interferon in melanoma patients: A systematic review
Trolio, R. D., Simeone, E., Lorenzo, G. D., Buonerba, C., & Ascierto, P. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.008 · Cited by 77
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
Egli, A., Levin, A., Santer, D. M., Joyce, M., O’Shea, D., Thomas, B., Lisboa, L. F., Barakat, K., Bhat, R. K., Fischer, K. P., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu144 · Cited by 77
Interferon-lambda and therapy for chronic hepatitis C virus infection
Donnelly, R. P., Dickensheets, H. L., & OʼBrien, T. R. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.07.002 · Cited by 76
Reovirus Receptors and Pathogenesis
Forrest, J. C., & Dermody, T. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9109-9115.2003 · Cited by 75
Haralambieva, I. H., Ovsyannikova, I. G., Kennedy, R. B., Vierkant, R. A., Pankratz, V. S., Jacobson, R. M., & Poland, G. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.083 · Cited by 70
Impact and Regulation of Lambda Interferon Response in Human Metapneumovirus Infection
Baños-Lara, M. D. R., Harvey, L., Mendoza, A., Simms, D. M., Chouljenko, V. N., Wakamatsu, N., Kousoulas, K. G., & Guerrero-Plata, A. (2014) · Journal of Virology · doi:10.1128/jvi.02897-14 · Cited by 69
Antiviral Type I and Type III Interferon Responses in the Central Nervous System
Sorgeloos, F., Kreit, M., Hermant, P., Lardinois, C., & Michiels, T. (2013) · Viruses · doi:10.3390/v5030834 · Cited by 64
Li, Y., Cheng, H., Zuo, X., Sheng, Y., Zhou, F.-S., Tang, X.-F., Tang, H.-Y., Gao, J.-P., Zhang, Z., He, S.-M., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101787 · Cited by 62
Mahlakõiv, T., Ritz, D., Mordstein, M., DeDiego, M. L., Enjuanes, L., Müller, M. A., Drosten, C., & Staeheli, P. (2012) · Journal of General Virology · doi:10.1099/vir.0.046284-0 · Cited by 60
Regulation of IFN-λ1 Promoter Activity (IFN-λ1/IL-29) in Human Airway Epithelial Cells
Siegel, R., Eskdale, J., & Gallagher, G. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003988 · Cited by 60
Ángel, J., Franco, M. A., Greenberg, H. B., et al. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313802 · Cited by 59
Human but Not Mouse Hepatocytes Respond to Interferon-Lambda In Vivo
Hermant, P., Demarez, C., Mahlakõiv, T., Staeheli, P., Meuleman, P., & Michiels, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087906 · Cited by 58
Zhou, P., Cowled, C. J., Marsh, G. A., Shi, Z., Wang, L., & Baker, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025385 · Cited by 56
Subversion of cytokine networks by virally encoded decoy receptors
Epperson, M. L., Lee, C. A., & Fremont, D. H. (2012) · Immunological Reviews · doi:10.1111/imr.12009 · Cited by 54
Kohli, A., Zhang, X., Yang, J., Russell, R. S., Donnelly, R. P., Sheikh, F. G., Sherman, A. C., Young, H. A., Imamichi, T., Lempicki, R. A., et al. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2012.01610.x · Cited by 53
Antiviral effect of interferon lambda against West Nile virus
Ma, D., Jiang, D., Qing, M., Weidner, J. M., Qu, X., Guo, H., Chang, J., Gu, B., Shi, P., Block, T. M., et al. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.03.006 · Cited by 53
Grayfer, L., Andino, F. D. J., & Robert, J. (2015) · Journal of Virology · doi:10.1128/jvi.00051-15 · Cited by 53
Role of Interferon-λ in Allergic Asthma
Koch, S., & Finotto, S. (2015) · Journal of Innate Immunity · doi:10.1159/000369459 · Cited by 48
Galmozzi, E., Viganò, M., & Lampertico, P. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12631 · Cited by 43
Cannella, F., Scagnolari, C., Selvaggi, C., Stentella, P., Recine, N., Antonelli, G., & Pierangeli, A. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0330-9 · Cited by 39
IFN-λ Exerts Opposing Effects on T Cell Responses Depending on the Chronicity of the Virus Infection
Misumi, I., & Whitmire, J. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301705 · Cited by 36
The Lambda Interferons: Guardians of the Immune–Epithelial Interface and the T-helper 2 Response
Gallagher, G. E., Megjugorac, N. J., Yu, R. Y.-L., Eskdale, J., Gallagher, G. E., Siegel, R., & Tollar, E. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0081 · Cited by 34
Potentials of Interferon Therapy in the Treatment of Pancreatic Cancer
Booy, S., Hofland, L. J., & van Eijck, C. H. J. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0157 · Cited by 33
The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases
Griffiths, S. J., Dunnigan, C. M., Russell, C. D., & Haas, J. (2015) · Journal of Innate Immunity · doi:10.1159/000369902 · Cited by 33
What Have We Learned from the IL28 Receptor Knockout Mouse?
Mordstein, M., Michiels, T., & Staeheli, P. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0061 · Cited by 33
Pietilä, T. E., Latvala, S., Österlund, P., & Julkunen, I. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1009651 · Cited by 33
IL ‐28B ( IFN ‐λ3) and IFN ‐α synergistically inhibit HCV replication
Shindo, H., Maekawa, S., Komase, K., Miura, M., Kadokura, M., Sueki, R., Komatsu, N., Shindo, K., Amemiya, F., Nakayama, Y., et al. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2012.01649.x · Cited by 27
Inhibition of Type III Interferon Activity by Orthopoxvirus Immunomodulatory Proteins
Bandi, P., Pagliaccetti, N. E., & Robek, M. D. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0049 · Cited by 26
Allergology international : official journal of the Japanese Society of Allergology
日本アレルギー学会 (1996) · Blackwell Science Ltd eBooks · Cited by 24
Interferon Lambda‐2 Levels in Sputum of Patients with Pulmonary Mycobacterium tuberculosis Infection
Travar, M., Vucic, M., & Petković, M. R. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12178 · Cited by 22
Interferon Lambda Genetic Polymorphisms and Viral Infection: The Tip of the Iceberg?
Russell, C. D., Griffiths, S. J., & Haas, J. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2261 · Cited by 13
Yui, K. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302849 · Cited by 13
Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis
de Lapuente, A. L., Alloza, I., Goertsches, R. H., Zettl, U. K., Urcelay, E., Arroyo, R., Comabella, M., Montalbán, X., Antigüedad, A. R., & Vandenbroeck, K. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.005 · Cited by 11
Cited by
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Self-citationThe continued threat of emerging flaviviruses
Pierson, T. C., & Diamond, M. S. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0714-0 · Cited by 1,098
Self-citationThe Role of Zinc in Antiviral Immunity
Read, S. A., Obeid, S., Ahlenstiel, C., & Ahlenstiel, G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz013 · Cited by 749
Bayer, A., Lennemann, N. J., Ouyang, Y., Bramley, J. C., Morosky, S., Marques, E. T. D. A., Cherry, S., Sadovsky, Y., & Coyne, C. B. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.008 · Cited by 546
Metadata
- Authors
- Lazear, H. M., Nice, T. J., & Diamond, M. S.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 43
- Issue
- 1
- Pages
- 15-28
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W1841904820
- Cited by
- 480
- References
- 150
- FWCI
- 18.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.